Clinical trial
A Cross-sectional Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
NCT01839526 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cross-sectional Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- May 31, 2013
- Completion date
- September 30, 2016
- Enrollment
- 39 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.